Experience

The Experience of our team with international clinical trials:

1.    PI - Phase III A Study the Venous Thromboembolic Risk 2016-2018 

2.    SC - Phase III Diabetes Mellitus type 2 (2014-2016 current) 

3.    SI - Phase III COPD treatment study (2014-2015) 

4.    SI - Phase III pneumonia treatment study, (2014-2015)

5.    Phase of the study III, Cardiological Study, Sub investigator (2014-2015) 

6.    Phase of the study III, Nephrology, Sub investigator (2014-2015) 

7.    Phase of the study III COPD and Cardiovascular Diseases; 

8.    Phase of the study III for type 2 Diabetes and Cardiovascular Diseases 

9.    Phase of the study III, for type 2 Diabetes and Cardiovascular Diseases, 

10.  Phase III, 1 study in Cardiovascular Diseases 

11.   Phase III Ponesimod in adult with relapsing multiple sclerosis 

12.   Phase of the study II, Indication Rheumatology, /2016 – 2018/ 

13.   Phase of the study III, Indication Nephrology, /2017 – 2018/ 

14.   Phase of the study III, Indication Cardiology, /2014 – 2015/ 

15.   Phase of the study III, Indication Nephrology, /2017 – 2018/ 

16.   Phase of the study III, Global Alliance for TB Drug Development 11/2017-12/2021 

17.   Phase of the study III, International Science and Technology Center (ISTC) 2016-2018, 

18.   Phase of the study III, randomized controlled multi-center trial, 01/2020-01/2025 

19.   Phase IV, New Diagnostics, TB- Disease, 2015-2017, 

20.  Phase IV, Tuberculosis, National Institute of Allergy and Infectious Diseases, 2015-2017 

21.   Phase of the study III-IV, in tuberculosis. 2013-2018 

22.  Phase of the study III Human Diagnostic, IC in TB Hospital, 2015 – 2016, 

23.  Swiss National Fund, Switzerland Georgia, 2009-2012, Disability Status Assessment project

24.  Timeline 2014-2015, Phase of the study III, Indication Cardiology, Role Subinvestigator

25.  Timeline 2017-2018, Phase of the study III, Indication Nephrology, Role Subinvestigator

26.  Timeline 2016-2018, Phase of the study II, Indication Rheumatology, Role Subinvestigator

27.  Timeline 2010 – 2013, Phase of the study III, Indication Cardiology, Role Subinvestigator

28.  Timeline 2020 -present, Phase of the study II, Indication Rheumatology, Role Subinvestigator

29.  Timeline 2019 -present, Phase of the study III, Indication Cardiology, Role Pharmacist

30.  Timeline 2017-2018, Phase of the study III, Indication Nephrology, Role Pharmacist

31.  Timeline 2014 – 2015, Phase of the study III, Indication Cardiology, Role Pharmacist

32.  Timeline 2011-12, Phase of the study III, Indication GOUT, Role Subinvestigator

33.  Timeline 2012-2014, Phase of the study II, Indication RA, Role Subinvestigator

34.  Timeline 2013-2014, Phase of the study II, Indication RA, Role Subinvestigator

35.  Timeline 2014-2015, Phase of the study III, Indication RA, Role Subinvestigator

36.  Timeline 2016-2018, Phase of the study II, Indication RA, Role Subinvestigator

37.  Timeline 2017-2018, Phase of the study II, Indication RA, Role Subinvestigator